Patent · US Active

Recombinant RNA particles and methods of use

US10174317B2 · kind B2 · utility

2Cited by
5References
31Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 13, 2015
Grant dateJan 8, 2019
Priority date
Expiry dateFeb 13, 2035

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2720/00043
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The present invention provides compositions and methods for the production and delivery of recombinant double-stranded RNA molecules (dsRNA) targeting pathogen sequences, which can be useful as an RNA vaccine. The compositions contain engineered double-stranded RNA particles (dsRPs) that can contain a double-stranded RNA molecule that can be a genome or portion of a genome, which can be enclosed in a capsid or coat protein. The dsRNA molecule also comprises an RNA sub-sequence that binds to a target sequence of a pathogenic organism. The dsRPs can be derived from wild-type viral organisms. The delivery of the dsRPs of the invention to an organism provides a protection to the organism from the pathogen.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.